PRLD EPS Estimates - Prelude Therapeutics Incorporated logo

PRLD EPS Estimates

Prelude Therapeutics Incorporated

$3.32
-$0.09(-2.64%)
37
Overall
60
Value
30
Tech
23
Quality
How is this score calculated?
Market Cap
$264.95M
Volume
422.33K
52W Range
$1.30 - $6.83
Target Price
$9.00

PRLD EPS estimates: the consensus estimate for Prelude Therapeutics Incorporated's current fiscal year is -$0.57 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.

PRLD EPS Estimates

EPS estimate, current quarter
$-0.14
EPS estimate, next quarter
$-0.16
EPS estimate, current year
$-0.57
EPS estimate, next year
$-0.73
EPS growth, 3-year
+23.77%
PRLD reported EPS by year
Fiscal yearEPS
2024$-1.68
2023$-2.02
2022$-2.44
2021$-2.43
2020$-4.56
ABCD
1SymbolPriceChangeVol
2PRLD$3.32-2.6%422.33K
3
4
5
6

Get Prelude Therapeutics Incorporated Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.